Record Information
Version1.0
Creation Date2019-07-14 16:19:47 UTC
Last Updated2019-10-01 21:37:49 UTC
CypComp IDCC00350
Compound Information
NameEllipticine
Structure ImageCtspamfjbxksoy uhfffaoysa n
InChIKeyCTSPAMFJBXKSOY-UHFFFAOYSA-N
PubChem ID3213
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
ReactantNon-ReactantNon-ReactantNon-ReactantReactantNon-ReactantReactantNon-ReactantReactant
References
  1. Stiborova M, Sejbal J, Borek-Dohalska L, Aimova D, Poljakova J, Forsterova K, Rupertova M, Wiesner J, Hudecek J, Wiessler M, Frei E: The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. Cancer Res. 2004 Nov 15;64(22):8374-80. doi: 10.1158/0008-5472.CAN-04-2202. [PubMed:15548707 ]
Download FileCC00350.sdf